Integrating early response biomarkers in pharmacokinetic models: A novel method to individualize the initial infliximab dose in patients with Crohn’s disease
Clin Transl Sci. 2025 Feb;18(2):e70086. doi: 10.1111/cts.70086. ABSTRACT The use of model-informed precision dosing to personalize infliximab has been shown to improve both the acquisition …